CGH analysis in Colombian patients: findings of 1374 arrays in a seven-year study

• Published in: Molecular cytogenetics Vol. 11; no. 1; p. 46
• Main Authors: García-Acero, Mary, Suárez-Obando, Fernando, Gómez-Gutiérrez, Alberto
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 22.08.2018; BioMed Central; BMC
• Subjects: Array CGH; Arrays; Chronic diseases; Cognitive ability; Congenital diseases; Copy number variation; Diagnosis; Genetic aspects; Genetic testing; Genetic variation; Genomes; Hybridization; Intellectual disabilities; Laboratories; Methods; Microdeletion syndrome; Microduplication syndrome; Patients; Physiological aspects; Software; Unusual finding; Colombia; Copy number variation; Unusual finding; Microdeletion syndrome; Array CGH; Microduplication syndrome
• ISSN: 1755-8166; 1755-8166
• DOI: 10.1186/s13039-018-0398-9

Array-based comparative genome hybridization (array CGH) is a first-line test used in the genetic evaluation of individuals with multiple anomalies, developmental delays, and cognitive deficits. In this study, we analyzed clinical indications and findings of array CGH tests of Colombian individuals forwarded to a reference laboratory over a period of seven years in order to evaluate the diagnostic performance of the test in our population. The results of 1374 array CGH analyses of Colombian individuals were referred to the Andean Reference Institute in Colombia (Instituto de Referencia Andino) during a 7-year period (2009-2015). Chromosomal imbalances were detected in 488 cases (35%), whereas 121 cases were classified as nonpathogenic variants, 65 cases (4.7%) were classified as variants of uncertain significance, and 302 cases (22%) were classified as abnormal or pathogenic. The most common findings in the abnormal and/or pathogenic set were deletions, followed by duplications and complex rearrangements. Variants in the carrier status of autosomal recessive diseases were identified as incidental findings in 29 subjects (2%). Clinical indications preceding the referral of aCGH in Colombian patients are not standardized and result in unexpected pathogenic variants as well as secondary findings that need careful interpretation. Development of local infrastructure will probably improve the communication between all stakeholders, to ensure accurate clinical diagnoses.